Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine vs ropivacaine for quadratus lumborum block in laparoscopic colorectal surgery
ChiCTR2500097657Phase 4Not yet recruiting
- Sponsor
- The First People's Hospital of Neijiang City
- Start
- Feb 2025
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of liposomal bupivacaine in colorectal cancer (CRC) (2 arms), sponsored by The First People's Hospital of Neijiang City. Primary endpoint: Postoperative pain scores at rest and during activity. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR2500097657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500097657.